Fancier fakes: Makers of bogus prescription drugs pose new challenges
Wednesday, January 6, 2010 - 23:35
in Mathematics & Economics
Manufacturers of counterfeit prescription drugs are embracing new tactics to deal with an estimated $75-billion-year market in knockoffs, a battle that is far from being won. That's the focus of an article in the current issue of Chemical and Engineering News (C and EN), ACS' weekly newsmagazine. Counterfeiting ploys include embracing the same technology that pharmaceutical companies use to identify their products as genuine...